FourThought Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$608K Sell
5,057
-116
-2% -$13.4K 0.05% 168
2025
Q4
$544K Sell
5,173
-523
-9% -$49.1K 0.05% 200
2025
Q3
$478K Sell
5,696
-903
-14% -$74.4K 0.04% 199
2025
Q2
$522K Buy
6,599
+507
+8% +$40.3K 0.05% 179
2025
Q1
$547K Buy
6,092
+906
+17% +$84.6K 0.06% 174
2024
Q4
$516K Buy
+5,186
New +$535K 0.05% 187
2024
Q2
Sell
-5,442
Closed -$718K 271
2024
Q1
$718K Sell
5,442
-44
-0.8% -$5.42K 0.08% 163
2023
Q4
$598K Sell
5,486
-1,213
-18% -$126K 0.08% 176
2023
Q3
$690K Sell
6,699
-1,467
-18% -$158K 0.1% 151
2023
Q2
$942K Sell
8,166
-86
-1% -$9.77K 0.12% 127
2023
Q1
$878K Buy
8,252
+357
+5% +$38.5K 0.12% 134
2022
Q4
$876K Buy
+7,895
New +$807K 0.13% 133

Other funds holding MRK

FourThought Financial Partners's MRK Position: Q1 2026 in Review

FourThought Financial Partners reduced its Merck (MRK) stake by 2.2% in Q1 2026, selling an estimated $13.4K and leaving 5,057 shares worth $608K. The position accounts for 0.05% of the portfolio, ranked #168.

FourThought Financial Partners first reported a position in MRK in Q4 2022 and has held it in 12 quarters since. The position peaked at $942K in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • FourThought Financial Partners held 5,057 shares of Merck worth $608K as of Q1 2026.
  • FourThought Financial Partners sold 116 Merck shares in Q1 2026, an estimated $13.4K.
  • Merck made up 0.05% of FourThought Financial Partners's portfolio in Q1 2026, its #168 holding.
  • FourThought Financial Partners first reported a position in Merck in Q4 2022 and has held it in 12 quarters since.
  • FourThought Financial Partners's Merck position peaked at $942K in Q2 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.